Lv1
50 积分 2025-01-06 加入
Rational combinations of targeted cancer therapies: background, advances and challenges
11天前
已完结
BMI status and its changes across adulthood in relation to all-cause mortality in metabolic dysfunction-associated steatotic liver disease
11天前
已关闭
Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy
1个月前
已完结
CDK12 inhibition mediates DNA damage and is synergistic with sorafenib treatment in hepatocellular carcinoma
1个月前
已完结
T follicular helper 17 (Tfh17) cells are superior for immunological memory maintenance
2个月前
已完结
Targeting STAT3 in Cancer Immunotherapy
2个月前
已完结
皖公网安备34019202002308
